The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase Ib/II study of enzalutamide (Enza) with and without ribociclib (Rib) in patients with metastatic castrate-resistant prostate cancer (mCRPC) that retains RB expression: RiboX study.
 
Kevin Zarrabi
Honoraria - Aptitude Health; Association of Community Cancer Centers (ACCC); Curio Science; OncLive Clinical Congress Consultants
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Eisai; Exelixis; Johnson & Johnson/Janssen; Pfizer; Survivornet
Research Funding - 858 Therapeutics (Inst); Amgen (Inst); DualityBio (Inst); Exelixis (Inst); IDEAYA Biosciences (Inst); Johnson & Johnson/Janssen (Inst); Vaccitech (Inst)
Travel, Accommodations, Expenses - Janux Therapeutics; Telix Pharmaceuticals
 
Susan Slovin
Consulting or Advisory Role - Aptitude Health; Bayer; Curio Science; Foundation Medicine; ITA Partners; MJH Life Sciences; Pfizer; PSI Pharma Support America
Research Funding - AstraZeneca
 
William Tester
No Relationships to Disclose
 
Benjamin Leiby
Consulting or Advisory Role - Alpha TAU Medical
Research Funding - GlaxoSmithKline (Inst)
 
Shannon Pileggi
No Relationships to Disclose
 
Karen Knudsen
Leadership - AstraZeneca; Exai Bio; Paradigm Health
Stock and Other Ownership Interests - AstraZeneca; Genomic Health; Pfizer
Honoraria - CellCentric; Genentech
Consulting or Advisory Role - Cell Centric; Genentech; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
David Smith
No Relationships to Disclose
 
Gurkamal Chatta
Consulting or Advisory Role - Cardinal Health
Research Funding - Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Cardinal Health
 
Karen Autio
Honoraria - MashupMedia
Consulting or Advisory Role - Fusion Pharmaceuticals; VIR Biotechnology
Research Funding - Amgen Astellas BioPharma (Inst); AstraZeneca (Inst); Janssen (Inst); Janux Therapeutics (Inst); Pfizer (Inst)
 
Wassim Abida
Honoraria - Aptitude Health; Clinical Education Alliance; Medscape; OncLive/MJH Life Sciences; Pfizer; Prostate Cancer Foundation; Roche; theMedNet; touchIME
Consulting or Advisory Role - AstraZeneca/MedImmune; Boundless Bio; Clovis Oncology; Daiichi Sankyo; DualityBio; Endeavor BioMedicines; IDEOlogy Health; Janssen; K36 Therapeutics; Laekna Therapeutics; MOMA Therapeutics; ORIC Pharmaceuticals; Pfizer; Tolmar
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Epizyme (Inst); Merus (Inst); MOMA Therapeutics (Inst); Nuvation Bio (Inst); ORIC Pharmaceuticals (Inst); TransThera Biosciences (Inst); Zenith Epigenetics (Inst)
(OPTIONAL) Uncompensated Relationships - Nuvation Bio
 
Howard Scher
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - AIQ Global; Bayer; Biodesix; Janssen Research & Development; Novartis; Promontory Therapeutics
Research Funding - AIQ Solutions (Inst); Astrin Biosciences (Inst); Biodesix (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Elucida Oncology - Intellectual Property Rights
Travel, Accommodations, Expenses - Bayer; Biodesix; Epic Sciences; Promontory Therapeutics; Prostate Cancer Foundation; WIRB-Copernicus Group
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Advancelle; Amgen; ARTbio; Arvinas; Bristol-Myers Squibb; Convergent Therapeutics; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; Isotopia; Lantheus Medical Imaging; Mashup Media; Molecular Partners; Soffinova; Transtherabio; Wren Laboratories; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Abbvie; APCCC; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis
 
William Kelly
Honoraria - Amgen; Janssen Oncology
Consulting or Advisory Role - Amgen; Bayer; Fusion Pharmaceuticals; Janssen Oncology
Research Funding - Amgen (Inst); Bayer (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology